Skip to content

Exactech Shoulder Post Market Clinical Follow-up Study

An Open Label, Multi-Center, Retrospective and Prospective Evaluation of Shoulder Arthroplasty Clinical and Radiographic Outcomes

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05603728
Enrollment
20000
Registered
2022-11-03
Start date
2007-07-19
Completion date
2031-12-31
Last updated
2026-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankylosing Spondylitis, Fracture, Infections, Osteo Arthritis Shoulders, Osteonecrosis, Post-traumatic Osteoarthritis, Rheumatoid Arthritis, Rotator Cuff Tear Arthropathy, Rotator Cuff Tears

Brief summary

The objective of this study is to collect and evaluate long-term clinical and radiographic outcomes data in order to better understand the safety and performance of the shoulder arthroplasty over time. This study will follow subjects long-term for a minimum of 10-years, without an early-term restriction on the amount of time they will be followed.

Interventions

None listed

Sponsors

Exactech
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient is indicated for shoulder arthroplasty (or has previously undergone shoulder arthroplasty) * Patient is skeletelly mature * Patient is expected to survive at least 2 years beyond surgery * Patient is willing to participate by complying with pre- and postoperative visit requirements * Patient is willing and able to read and sign a study informed consent form

Exclusion criteria

* Osteomyelitis of the proximal humerus or scapula; if a systemic infection or a secondary remote infection is suspected or confirmed, implantation should be delayed until infection is resolved * Inadequate or malformed bone that precludes adequate support or fixation of the prosthesis * Medial humeral bone loss resulting in compromised humeral stem fixation * Proximal humeral bone loss extending distal to the surgical neck where there is compromised humeral stem fixation * Neuromuscular disorders that do not allow control of the joint * Significant injury to the brachial plexus * Non-functional deltoid muscles * Patient's age, weight, or activity level would cause the surgeon to expect early failure of the system * The patient is unwilling or unable to comply with the post-operative care instructions * Alcohol, drug, or other subtance abuse * Any disease state that could adversaly affect the function or longevity of the implant * Patient is pregnant * Patient is a prisoner * Patient is contraindicated for the surgery * Revision cases in which a stemmed humeral component was used (Stemless Shoulder System) * Metal allergy or sensitivity to the implants materials (Stemless Shoulder System) * Acute fracture of the proximal humerus and displacement of the tuberosities, displaced three or four part fractures of the proximal humerus (hemi-arthroplasty), or acture fracture of the proximal humerus with failure of the glenohumeral joint (total anatomic shoulder arthroplasty) (Stemless Shoulder System) * Acute fracture of the proximal humerus in combination with degenerative diseases of the glenohumeral joint and a grossly deficient, irreparable rotator cuff resulting in superior migration of the humeral head (reverse total shoulder arthroplasty) (Stemless Shoulder System)

Design outcomes

Primary

MeasureTime frameDescription
ConstantThrough study completion, an average of 1 per yearConstant Shoulder Score - 100 points scale about pain, Activities of daily living, Strength test, and Range of Motions questions about shoulder where 100 % corresponds to the highest pain
ASESThrough study completion, an average of 1 per yearAmerican Shoulder and Elbow Surgeons Score (ASES) - 100 points scale about shoulder pain and performance evaluation in activities of daily living where 100 indicates the best shoulder condition
Oxford Score (may be used as an optional form for surgeons in the United Kingdom)Through study completion, an average of 1 per yearOxford Shoulder Score (OSS) - 12 questions assessing outcomes of shoulder surgery and its impact on patients' quality of life of degenerative conditions such as arthritis and rotator cuff problems - Maximum score is 60 and indicates greater degree of disability
TESS (may be used as specific forms related to the pre-operative condition/diagnosis)Through study completion, an average of 1 per yearToronto Extremity Salvage Score (TESS) - Patient functional assessment following for surgery for musculoskeletal tumors (Humeral Reconstruction Stem only) - 100-point score where higher score indicates a better outcome
MSTS (may be used as specific forms related to the pre-operative condition/diagnosis)Through study completion, an average of 1 per yearMusculoskeletal Tumor Society (MSTS) - 30 points \[6 times (range 0-5)\], simple measure of the upper extremity function (Humeral Reconstruction Stem only) - The maximum corresponds to the best score

Countries

Canada, France, Germany, Italy, United Kingdom, United States

Contacts

CONTACTRachael Craig
rachael.craig@advita.com1-833-423-8482
CONTACTSandrine Angibaud
sandrine.angibaud@advita.com1-833-423-8482
PRINCIPAL_INVESTIGATORJonathan Wright, MD

UF Health Orthopaedics and Sports Medicine Institute

PRINCIPAL_INVESTIGATORYoung Kwon, MD

Hospital for Joint Diseases - NYU Langone Health

PRINCIPAL_INVESTIGATORRichard Friedman, MD

Charleston Orthopaedic Associates

PRINCIPAL_INVESTIGATORRichard Jones, MD

Southeastern Orthopedics and Spine

PRINCIPAL_INVESTIGATORHoward Routman, DO

Florida Atlantis Orthopaedics

PRINCIPAL_INVESTIGATORRyan Simovitch, MD

HSS

PRINCIPAL_INVESTIGATORGeoffrey Abrams, MD

Stanford Health Care

PRINCIPAL_INVESTIGATORPierre Henri Flurin, MD

Centre de l'Arthrose

PRINCIPAL_INVESTIGATORHarry Brownlow, MD

Circle Health Group

PRINCIPAL_INVESTIGATOROliver Donaldson, MD

Yeovil District Hospital NHS Foundation

PRINCIPAL_INVESTIGATORChris Roberts, MD

Ipswich Hospital

PRINCIPAL_INVESTIGATORChris Peach, MD

University Hospital South Manchester

PRINCIPAL_INVESTIGATORAngelo Di Giunta, MD

Policlinico Morgagni

PRINCIPAL_INVESTIGATORAlfonso Romano, MD

Campolongo Hospital

PRINCIPAL_INVESTIGATORSean Grey, MD

Orthopaedic and Spine Center of the Rockies

PRINCIPAL_INVESTIGATORChad Manke, MD

Altantic Orthopaedics Specialists

PRINCIPAL_INVESTIGATORRick Papandrea, MD

Orthopaedic Associates of Wisconsin

PRINCIPAL_INVESTIGATORAndrew Chambler, MD

The Sulis Hospital Bath

PRINCIPAL_INVESTIGATORCurt Noel, MD

Crystal Clinic Orthopaedic

PRINCIPAL_INVESTIGATORStephen Parada, MD

Orthopedic and Sports Medicine

PRINCIPAL_INVESTIGATORAri Youderian, MD

South County Orthopedic Specialists

PRINCIPAL_INVESTIGATORIan Byram, MD

Bone and Joint Institute of Tennessee

PRINCIPAL_INVESTIGATORTewfik Benkalfate, MD

Clinique Mutualiste la Sagesse

PRINCIPAL_INVESTIGATORPeter McCann, MD

Lenox Health Greenwich Village

PRINCIPAL_INVESTIGATORJared Mahylis, MD

Henry Ford Health

PRINCIPAL_INVESTIGATORBradley Schoch, MD

Mayo Clinic

PRINCIPAL_INVESTIGATORStephan Pill, MD

Steadman Hawkins Clinic of the Carolinas

PRINCIPAL_INVESTIGATORScott Trenhaile, MD

OrthoIllinois

PRINCIPAL_INVESTIGATORBryan Butler, MD

Orthopaedic Medical Group of Tampa Bay

PRINCIPAL_INVESTIGATORBen Gooding, MD

Nottingham City Hospital

PRINCIPAL_INVESTIGATORBrad Carofino, MD

Altantic Orthopaedics Specialist

PRINCIPAL_INVESTIGATORBen Sears, MD

Western Orthopaedics

PRINCIPAL_INVESTIGATORKenneth Faber, MD

St Joseph's Health Care

PRINCIPAL_INVESTIGATORJaicharan Iyengar, MD

Alpine Orthopaedic Medical Group

PRINCIPAL_INVESTIGATOROke Anakwenze, MD

Duke Department of Orthopedic Surgery

PRINCIPAL_INVESTIGATORThomas Obermeyer, MD

Barrington Orthopedic

PRINCIPAL_INVESTIGATORAlison Armstrong, MD

Leicester General Hospital

PRINCIPAL_INVESTIGATORGeorge Malal, MD

Bedford Hospital

PRINCIPAL_INVESTIGATORDiego Lima, MD

Florida Atlantis Orthopaedics

PRINCIPAL_INVESTIGATORRemi Charvet, MD

Clinique Belledone

PRINCIPAL_INVESTIGATORJorn Steinbeck, MD

Orthopadische Praxisklinik Von Vincke

PRINCIPAL_INVESTIGATORThomas Tischer, MD

Malteser Waldkrankenhaus Erlangen

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 18, 2026